Tarsus Pharmaceuticals, Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18
	8-K	10-K	10-K	10-K	S-1/A
Assets
Cash and equivalents	71.7	171.3	168.1	58.0	2.4
Short-term investments	145.4	0.5
Other current assets	8.3	4.1	2.5	0.1	0.0
Total current assets	225.4	176.0	170.7	58.0	2.4
Property, plant, and equipment, net	1.0	0.8	0.5	0.2	0.0
Long-term investments	0.4
Other fixed assets	0.6	1.1	0.1	0.0
Total assets	227.9	178.9	172.0	58.3	2.4

Accrued expenses	5.5	2.8	1.0	0.3	0.0
Short-term debt	0.0	0.0	0.0	0.0	0.0
Other current liabilities	9.9	8.7	4.3	0.5	0.2
Total current liabilities	15.4	11.5	5.4	0.8	0.2
Other liabilities	19.5	0.7	0.6	0.1
Total liabilities	35.0	12.2	6.0	0.9	0.2

Shareholders' equity [+]	192.9	166.7	166.0	57.4	2.2
Paid-in capital	301.7	213.4	198.8	0.0	0.0
Retained earnings	-108.8	-46.7	-32.8	-6.0	-1.4
Tangible shareholders' equity	192.9	166.7	166.0	57.4	2.2